Table 4.
Women (n=275) | Men (n=204) | ||||||||
---|---|---|---|---|---|---|---|---|---|
Univariate | Multivariatea | Univariate | Multivariatea | ||||||
Variables | OR(95% Cl) | P | OR(95% Cl) | P | Variables | OR(95% Cl) | P | OR(95% Cl) | P |
FPG ≥ 5.55 mmol/L | 3.79(2.23–6.46) | <0.001 | 3.33(1.87–5.92) | <0.001 | FPG≥ 5.55 mmol/L | 1.60(0.90–2.84) | 0.11 | ||
<5.55 | 1.00 | 1.00 | <5.55 | 1.00 | |||||
WC ≥ 88 cm | 3.77(1.82–7.83) | <0.001 | WC≥ 102 cm | 4.36(2.29–8.28) | <0.001 | 2.36(1.08–5.17) | 0.03 | ||
<88 | 1.00 | <102 | 1.00 | 1.00 | |||||
BMI ≥ 25 kg/m2 | N/Ab | BMI≥ 30 kg/m2 | 4.17(2.27–7.68) | <0.001 | 2.55(1.21–5.38) | 0.01 | |||
<25 | 0.00 | <30 | 1.00 | 1.00 | |||||
SBP ≥ 130 mmHg | 1.33(0.77–2.30) | 0.31 | SBP≥ 130 mmHg | 1.88(1.06–3.34) | 0.03 | 2.17(1.06–4.48) | 0.04 | ||
<130 | 1.00 | <130 | 1.00 | 1.00 | |||||
DBP ≥ 85 mmHg | 0.92(0.36–2.39) | 0.87 | DBP≥ 85 mmHg | 0.82(0.41–1.63) | 0.57 | ||||
<85 | 1.00 | <85 | 1.00 | ||||||
TG ≥ 1.70 mmol/L | 3.60(2.00–6.45) | <0.001 | 2.72(1.43–5.16) | <0.001 | TG≥ 1.70 mmol/L | 2.55(1.43–4.54) | <0.001 | 2.02(1.04–3.91) | 0.04 |
<1.70 | 1.00 | 1.00 | <1.70 | 1.00 | 1.00 | ||||
HDL-C < 1.30 mmol/L | 3.00(1.80–5.01) | <0.001 | 2.64(1.50–4.66) | <0.001 | HDL-C< 1.04 mmol/L | 2.18(1.22–3.90) | 0.008 | 1.96(1.01–3.80) | 0.046 |
≥ 1.30 | 1.00 | 1.00 | ≥ 1.04 | 1.00 | 1.00 | ||||
TC ≥ 5.18 mmol/L | 0.97(0.59–1.59) | 0.90 | TC≥ 5.18 mmol/L | 1.37(0.77–2.42) | 0.29 | ||||
<5.18 | 1.00 | <5.18 | 1.00 | ||||||
LDL-C ≥ 4.14 mmol/L | 0.64(0.29–1.45) | 0.29 | LDL-C≥ 4.14 mmol/L | 0.96(0.41–2.25) | 0.93 | ||||
<4.14 | 1.00 | <4.14 | 1.00 |
In multivariate analysis, only variables that were statistically significant are listed.
N/A- Not applicable because the odds of insulin resistance in women with BMI <25kg/m2 equaled zero.